US Cardiovascular Device Market Size, Share, Trends, Industry Analysis Report By Device Type (Diagnostic and Monitoring Devices, Therapeutic and Surgical Device), By Application, By End Use

Description

List of Tables

The U.S. cardiovascular device market size is expected to reach USD 38.49 billion by 2034, according to a new study by Polaris Market Research. The report "U.S. Cardiovascular Device Market Size, Share, Trends, Industry Analysis Report By Device Type (Diagnostic and Monitoring Devices, Therapeutic and Surgical Device), By Application, By End Use - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The U.S. cardiovascular device market refers to the ecosystem of medical technologies designed to diagnose, monitor, and treat various heart-related conditions, including coronary artery disease, arrhythmias, heart failure, and structural abnormalities.

The market continues to expand, driven by a surge in chronic cardiovascular conditions linked to aging populations and lifestyle-induced risk factors. Increasing adoption of minimally invasive surgery has accelerated demand for advanced surgical and interventional tools, particularly stents, catheters, and implantable cardiac devices. Healthcare systems are prioritizing early diagnosis and real-time monitoring, prompting broader usage of wearable cardiac monitors and remote telemetry solutions. Device manufacturers are focusing on smart, data-integrated platforms that allow clinicians to personalize treatment and improve long-term outcomes. Industry trends show strong momentum in AI-driven diagnostics and leadless technologies, which are improving procedural precision and reducing post-operative complications.

Growth in ambulatory surgical settings and outpatient cardiology care creates lucrative opportunities for market players offering compact, portable, and low-maintenance devices tailored to shorter stays and lower costs. Players are leveraging collaborations with health systems and digital health platforms to create holistic cardiovascular care models. Investments in R&D remain high, targeting innovations in bioresorbable materials, wireless communication, and closed-loop monitoring. The shift toward value-based healthcare is also creating space for technologies that deliver both clinical efficacy and economic efficiency. Regulatory support for accelerated approvals of breakthrough cardiac devices is supporting faster commercialization and broader adoption.

U.S. Cardiovascular Device Market Report Highlights

By device type, the therapeutic and surgical devices segment accounted for approximately 70% of the revenue share in 2024, due to the rising number of interventional cardiology procedures across hospitals and specialty cardiac centers.

By application, the coronary artery disease segment accounted for the largest revenue share in 2024, driven by its widespread prevalence high incidence among aging individuals.

By end use, the hospitals segment accounted for approximately 60% of the revenue share in 2024, due to their comprehensive infrastructure for handling complex cardiovascular interventions and emergency cardiac care.

A few key market players are Abbott Laboratories; B. Braun Melsungen AG; Biotronik SE & Co.KG; Boston Scientific Corporation; C. R. Bard, Inc.; Cook Medicals; Lepu Medicals; Liaoning Biomedical Materials; Medtronic Plc; Meril Life Sciences; MicroPort Scientific Corporation; Terumo Corporation; Translumina GmbH; Vascular Concepts; Jude Medical, Inc.; and Edward lifesciences corporation.

Polaris Market Research has segmented the U.S. cardiovascular device market report on the basis of device type, application, end use, and region:

By Device Type (Revenue USD Billion, 2020-2034)

Diagnostic and Monitoring Devices

Electrocardiogram

Remote Cardiac Monitoring

MRI

Others

Therapeutic and Surgical Devices

Ventricular Assist Devices

Cardiac Rhythm Management Devices

Catheter

Stents

Others

By Application (Revenue USD Billion, 2020-2034)

Heart Failure

Cardiac Arrhythmia

Coronary Artery Disease

Others

By End Use (Revenue USD Billion, 2020-2034)

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Product Code: PM5834

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Device Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. US Cardiovascular Device Market Insights

4.1. US Cardiovascular Device Market - Market Snapshot
4.2. US Cardiovascular Device Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Aging Population and Increased Surgical Interventions
  - 4.2.1.2. Increasing Awareness and Preventive Screenings
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of the Devices
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. US Cardiovascular Device Market Trends
4.6. Value Chain Analysis

5. US Cardiovascular Device Market, by Device Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. US Cardiovascular Device Market, by Device Type, 2020-2034 (USD billion)
5.3. Diagnostic And Monitoring Devices
- 5.3.1. US Cardiovascular Device Market, by Diagnostic and Monitoring Devices, 2020-2034 (USD billion)
- 5.3.2. Electrocardiogram
  - 5.3.2.1. US Cardiovascular Device Market, by Electrocardiogram, 2020-2034 (USD billion)
- 5.3.3. Remote Cardiac Monitoring
  - 5.3.3.1. US Cardiovascular Device Market, by Remote Cardiac Monitoring, 2020-2034 (USD billion)
- 5.3.4. MRI
  - 5.3.4.1. US Cardiovascular Device Market, by MRI, 2020-2034 (USD billion)
- 5.3.5. Others
  - 5.3.5.1. US Cardiovascular Device Market, by Others, 2020-2034 (USD billion)
5.4. Therapeutic And Surgical Devices
- 5.4.2. Ventricular Assist Devices
  - 5.4.2.1. US Cardiovascular Device Market, by Ventricular Assist Devices, 2020-2034 (USD billion)
- 5.4.3. Cardiac Rhythm Management Devices
  - 5.4.3.1. US Cardiovascular Device Market, by Cardiac Rhythm Management Devices, 2020-2034 (USD billion)
- 5.4.4. Catheter
  - 5.4.4.1. US Cardiovascular Device Market, by Catheter, 2020-2034 (USD billion)
- 5.4.5. Stents
  - 5.4.5.1. US Cardiovascular Device Market, by Stents, 2020-2034 (USD billion)
- 5.4.6. Others
  - 5.4.6.1. US Cardiovascular Device Market, by Others, 2020-2034 (USD billion)

6. US Cardiovascular Device Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. US Cardiovascular Device Market, by Application, 2020-2034 (USD billion)
6.3. Heart Failure
- 6.3.1. US Cardiovascular Device Market, by Heart Failure, 2020-2034 (USD billion)
6.4. Cardiac Arrhythmia
- 6.4.1. US Cardiovascular Device Market, by Cardiac Arrhythmia, 2020-2034 (USD billion)
6.5. Coronary Artery Disease
- 6.5.1. US Cardiovascular Device Market, by Steel Plate, 2020-2034 (USD billion)
6.6. Others
- 6.6.1. US Cardiovascular Device Market, by Others, 2020-2034 (USD billion)

7. US Cardiovascular Device Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. US Cardiovascular Device Market, by End Use, 2020-2034 (USD billion)
7.3. Hospitals
- 7.3.1. US Cardiovascular Device Market, by Hospitals, 2020-2034 (USD billion)
7.4. Ambulatory Surgical Centers
- 7.4.1. US Cardiovascular Device Market, by Ambulatory Surgical Centers, 2020-2034 (USD billion)
7.5. Specialty Clinics
- 7.5.1. US Cardiovascular Device Market, by Specialty Clinics, 2020-2034 (USD billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. B. Braun Melsungen AG
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Biotronik SE & Co.KG
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Boston Scientific Corporation
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. C. R. Bard, Inc.
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Cook Medicals
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Lepu Medicals
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Liaoning Biomedical Materials
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Medtronic Plc
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Meril Life Sciences
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. MicroPort Scientific Corporation
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
9.12. Terumo Corporation
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
9.13. Translumina GmbH
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
9.14. Vascular Concepts
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
9.15. Jude Medical, Inc.
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
9.16. Edward lifesciences corporation
- 9.16.1. Company Overview
- 9.16.2. Financial Performance
- 9.16.3. Product Benchmarking
- 9.16.4. Recent Development

Product Code: PM5834

List of Tables:

Table 1 US Cardiovascular Device Market, by Device Type, 2020-2034 (USD billion)
Table 2 US Cardiovascular Device Market, by Application, 2020-2034 (USD billion)
Table 3 US Cardiovascular Device Market, by End Use, 2020-2034 (USD billion)

List of Figures:

Figure 1. US Cardiovascular Device Market, 2020-2034 (USD billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Device Methodology: Top-Down & Bottom-Up Price
Figure 4. Porter's Five Forces
Figure 5. Market by Device Type
Figure 6. US Cardiovascular Device Market, by Device Type, 2024 & 2034 (USD billion)
Figure 7. Market by Application
Figure 8. US Cardiovascular Device Market, by Application, 2024 & 2034 (USD billion)
Figure 9. Market by End Use
Figure 10. US Cardiovascular Device Market, by End Use, 2024 & 2034 (USD billion)
Figure 11. US Cardiovascular Device Market Assessment, By Geography, 2020-2034 (USD billion)
Figure 12. Strategic Analysis - US Cardiovascular Device Market

US Cardiovascular Device Market Size, Share, Trends, Industry Analysis Report By Device Type (Diagnostic and Monitoring Devices, Therapeutic and Surgical Device), By Application, By End Use - Market Forecast, 2025-2034

Description

Table of Contents

List of Tables

U.S. Cardiovascular Device Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Device Methodology

4. US Cardiovascular Device Market Insights

5. US Cardiovascular Device Market, by Device Type

6. US Cardiovascular Device Market, by Application

7. US Cardiovascular Device Market, by End Use

8. Competitive Landscape

9. Company Profiles

List of Tables:

List of Figures: